Clinical trial
Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)
NCT00350779
Study timeline
Study start (actual)2006-06-12Date precision: day
Registry last updated2017-05-12
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes Mellitusunresolved
Interventions
sitagliptinDRUG · verified · RxNorm: sitagliptin
rosiglitazoneDRUG · verified · RxNorm: rosiglitazone
metforminDRUG · verified · RxNorm: metformin
glipizideDRUG · verified · RxNorm: glipizide
Sponsors & collaborators
Merck Sharp & Dohme LLClead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00350779 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.